SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286,397 | +22.1% | 6,091 | +9.0% | 0.00% | 0.0% |
| Q1 2023 | $234,513 | +1703.9% | 5,589 | +1290.3% | 0.00% | – |
| Q2 2022 | $13,000 | -35.0% | 402 | -32.8% | 0.00% | – |
| Q1 2022 | $20,000 | +100.0% | 598 | +160.0% | 0.00% | – |
| Q4 2021 | $10,000 | -47.4% | 230 | -47.6% | 0.00% | – |
| Q3 2021 | $19,000 | -36.7% | 439 | -16.9% | 0.00% | – |
| Q2 2021 | $30,000 | -23.1% | 528 | +2.3% | 0.00% | – |
| Q1 2021 | $39,000 | -50.0% | 516 | -42.9% | 0.00% | -100.0% |
| Q4 2020 | $78,000 | +1014.3% | 903 | +692.1% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 114 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +400.0% | 114 | +2750.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 4 | -69.2% | 0.00% | – |
| Q1 2018 | $2,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |